Christoph Loddenkemper
Overview
Explore the profile of Christoph Loddenkemper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
218
Citations
8815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moos V, Kruger J, Allers K, Moter A, Kikhney J, Kuhl A, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39978372
Background: Previous studies have shown that intravenous ceftriaxone or meropenem for 14 days, followed by oral trimethoprim-sulfamethoxazole for 1 year, cures 98% of people with Whipple's disease. However, intravenous therapy...
2.
Kikhney J, Friesen I, Wiesener S, Kursawe L, Loddenkemper C, Zundorf J, et al.
Lancet Microbe
. 2024 Nov;
5(12):100934.
PMID: 39491876
Background: Mycobacterium chelonae is a rare cause of infective endocarditis that is difficult to diagnose and treat. After we found M chelonae in a series of patients, we aimed to...
3.
Alterations of Central Liver Metabolism of Pediatric Patients with Non-Alcoholic Fatty Liver Disease
Berndt N, Hudert C, Eckstein J, Loddenkemper C, Henning S, Bufler P, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36232372
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and is associated with overweight and insulin resistance (IR). Almost nothing is known about in vivo...
4.
Branchi F, Wiese J, Heldt C, Manna S, Dony V, Loddenkemper C, et al.
Dig Liver Dis
. 2022 Jul;
54(12):1649-1656.
PMID: 35850920
Background: Flow cytometry of intestinal lymphocytes is discussed to be a stronger predictor of enteropathy-associated T-cell lymphoma development in refractory celiac disease than T-cell clonality analysis. Aims: To investigate possible...
5.
Bojarski C, Tangermann P, Barmeyer C, Buchkremer J, Kiesslich R, Ellrichmann M, et al.
Gut
. 2021 Sep;
71(8):1567-1576.
PMID: 34544843
Objective: A considerable proportion of patients with irritable bowel syndrome (IBS) may be wheat-sensitive and respond to a gluten-free diet (GFD) although they do not have coeliac disease. However, a...
6.
Derungs T, Leo F, Loddenkemper C, Schneider T
Lancet Infect Dis
. 2021 Aug;
21(10):e334-e340.
PMID: 34425068
Disseminated nocardiosis is a rare, life-threatening disease. Particularly at risk are immunocompromised patients, highlighting the crucial role of host factors. Conventional intensive antibiotic treatment has improved survival rates, but the...
7.
Lehmann M, Allers K, Heldt C, Meinhardt J, Schmidt F, Rodriguez-Sillke Y, et al.
Mucosal Immunol
. 2021 Aug;
14(6):1381-1392.
PMID: 34420043
The SARS-CoV-2 pandemic has so far claimed over three and a half million lives worldwide. Though the SARS-CoV-2 mediated disease COVID-19 has first been characterized by an infection of the...
8.
Hudert C, Tzschatzsch H, Rudolph B, Loddenkemper C, Holzhutter H, Kalveram L, et al.
Acta Biomater
. 2021 Jan;
123:178-186.
PMID: 33472102
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents. About 30% of patients with NAFLD progress to the more severe condition of nonalcoholic...
9.
Kalveram L, Schunck W, Rothe M, Rudolph B, Loddenkemper C, Holzhutter H, et al.
Prostaglandins Leukot Essent Fatty Acids
. 2021 Jan;
164:102229.
PMID: 33388475
Non-alcoholic fatty liver disease (NAFLD) is a significant health burden in obese children for which there is currently no specific therapy. Preclinical studies indicate that epoxyeicosanoids, a class of bioactive...
10.
Hudert C, Tzschatzsch H, Rudolph B, Blaker H, Loddenkemper C, Muller H, et al.
Invest Radiol
. 2018 Nov;
54(4):198-203.
PMID: 30444796
Objectives: Today, nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adults alike. Yet, the noninvasive evaluation of disease severity remains a diagnostic challenge....